Importantly, in vivo, injection of apoptotic lung cancer cells or recombinant WISP-1 could induce this signaling axis to inhibit CAF activation and reduction in metastatic tumors (Kim et al., 2022). The gene discussed is CCN4; the disease is lung carcinoma.